Related Experiment Video
Updated: May 15, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Predictors of medication non-adherence for vasculitis patients
Delesha M Carpenter1, Susan L Hogan, Robert F Devellis
1Division of Pharmaceutical Outcomes and Policy, CB#7573, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA. dmcarpenter@unc.edu
Clinical Rheumatology
|January 15, 2013
Summary
Younger age and depressive symptoms predict medication non-adherence in vasculitis patients. Addressing side effects and depression is crucial for improving adherence in this population.
Area of Science:
- Rheumatology
- Patient Adherence Research
- Psychosomatic Medicine
Background:
- Medication non-adherence is a significant challenge in managing chronic conditions like vasculitis.
- Understanding factors influencing adherence is critical for improving patient outcomes.
- Vasculitis management requires consistent medication use, making adherence a key concern.
Purpose of the Study:
- To identify demographic, clinical, regimen-related, intrapersonal, and interpersonal factors predicting medication non-adherence in vasculitis patients.
- To explore variations in adherence based on medication type and the impact of drug-related side effects.
- To provide evidence-based insights for enhancing treatment adherence in vasculitis management.
Main Methods:
- A cohort of 228 vasculitis patients completed online baseline and 3-month follow-up surveys.
- Data collected included demographic, clinical, regimen-related (side effects), intrapersonal (depressive symptoms), and interpersonal factors.
- Medication non-adherence was assessed using the Vasculitis Self-Management Survey, with regression analysis identifying predictors.
Main Results:
- Younger age, female sex, experiencing side effects, and higher depressive symptoms were associated with increased non-adherence.
- Linear regression identified younger age and depressive symptoms as significant predictors of worse adherence.
- Patients experiencing side effects showed lower adherence for most vasculitis medication types.
Conclusions:
- Multiple factors, including younger age and depressive symptoms, significantly impact medication adherence in vasculitis patients.
- Healthcare providers should proactively discuss adherence and side effects, especially with younger patients and those exhibiting depressive symptoms.
- Targeted interventions addressing psychological and side-effect concerns may improve vasculitis treatment adherence.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...